Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cancer Trials Ireland
Pilot Study- Primary Objectives:
* Prospective evaluation of the technical feasibility of integrating PET-CT fusion in St Luke's Hospital
* Rate of PET-CT Scan based treatment delivery
Pilot Study- Secondary Objectives:
-Comparison of GTV, PTV and OAR DVHs between conventional 3-DCRT plan and PET-CT based 3-DCRT plan.
Phase II Study- Primary Objective:
-The safety of PET-CT scan based radiotherapy, with regard to loco-regional disease control.
Phase II Study- Secondary Objectives:
-Comparison of GTV, PTV and OAR DVHs between conventional 3-DCRT plan and PET-CT based 3-DCRT plan.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically proven (biopsy or cytology) NSCLC (SCC, Adenocarcinoma, Large Cell)
TNM clinical non-operable stage I/II and non-resectable stage IIIa/b without pleural effusion
Measurable disease
No other malignancy, except non-melanomatous skin cancer, within 5 years prior to participation in this study; the disease-free interval from any prior carcinoma must be continuous
Patient suitable for radical 3-DCRT
ECOG-Performance status ≤ 2 / KPS \> or equal to 60
Weight loss \<10% within the 3 months prior to diagnosis
No prior radiotherapy to the thorax
Patient is suitable for lung-board immobilisation
No chemotherapy received prior to planning PET-CT scan
Age 18 and over
Provision of written informed consent
You may not be if
Evidence of any other significant clinical disorder or laboratory finding that makes it undesirable for the patient to participate in the trial or if it is felt by the research / medical team that the patient may not be able to comply with the protocol.